AU2004273965B2 - DNA vaccine compositions and methods of use - Google Patents
DNA vaccine compositions and methods of use Download PDFInfo
- Publication number
- AU2004273965B2 AU2004273965B2 AU2004273965A AU2004273965A AU2004273965B2 AU 2004273965 B2 AU2004273965 B2 AU 2004273965B2 AU 2004273965 A AU2004273965 A AU 2004273965A AU 2004273965 A AU2004273965 A AU 2004273965A AU 2004273965 B2 AU2004273965 B2 AU 2004273965B2
- Authority
- AU
- Australia
- Prior art keywords
- dna
- hiv
- gene
- immunogenic composition
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50319703P | 2003-09-16 | 2003-09-16 | |
| US60/503,197 | 2003-09-16 | ||
| US10/941,164 | 2004-09-15 | ||
| US10/941,164 US7488485B2 (en) | 2003-09-16 | 2004-09-15 | DNA vaccine compositions and methods of use |
| PCT/US2004/030512 WO2005027844A2 (en) | 2003-09-16 | 2004-09-16 | Dna vaccine compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004273965A1 AU2004273965A1 (en) | 2005-03-31 |
| AU2004273965B2 true AU2004273965B2 (en) | 2010-12-09 |
Family
ID=34381064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004273965A Ceased AU2004273965B2 (en) | 2003-09-16 | 2004-09-16 | DNA vaccine compositions and methods of use |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7488485B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1667523B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4989224B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004273965B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0414442A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2538840C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1667523T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2399875T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL174325A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ545954A (cg-RX-API-DMAC7.html) |
| PL (1) | PL1667523T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1667523E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005027844A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488485B2 (en) * | 2003-09-16 | 2009-02-10 | University Of Kansas Medical Center | DNA vaccine compositions and methods of use |
| US8765140B2 (en) * | 2003-09-16 | 2014-07-01 | University Of Kansas Medical Center | DNA vaccine compositions with HIV/SIV gene modifications |
| ES2541771T3 (es) * | 2005-05-03 | 2015-07-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Expresión de una proteína mitocondrial mediante un enfoque alotópico mejorado |
| US7585675B2 (en) * | 2005-11-15 | 2009-09-08 | University Of Kansas Medical Center | Inhibition of HIV and SHIV replication with antisense interleukin-4 |
| FR2979919B1 (fr) * | 2011-09-12 | 2015-12-11 | Centre Nat Rech Scient | Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1 |
| US20130337009A1 (en) * | 2012-02-21 | 2013-12-19 | Immunogenetix Therapeutics, Inc. | Chimeric dna vaccine compositions and methods of use |
| AU2020315598B2 (en) | 2019-07-16 | 2024-12-12 | Gilead Sciences, Inc. | HIV vaccines and methods of making and using |
| CA3202466A1 (en) | 2021-01-14 | 2022-07-21 | Jiani LI | Hiv vaccines and methods of using |
| AU2022208435A1 (en) | 2021-01-18 | 2023-08-10 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030158131A1 (en) * | 2000-10-23 | 2003-08-21 | Anna Aldovini | DNA vectors containing mutated HIV proviruses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5741492A (en) * | 1996-01-23 | 1998-04-21 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| US6531123B1 (en) * | 1997-05-01 | 2003-03-11 | Lung-Ji Chang | Lentiviral vectors |
| US7488485B2 (en) * | 2003-09-16 | 2009-02-10 | University Of Kansas Medical Center | DNA vaccine compositions and methods of use |
-
2004
- 2004-09-15 US US10/941,164 patent/US7488485B2/en not_active Expired - Fee Related
- 2004-09-16 AU AU2004273965A patent/AU2004273965B2/en not_active Ceased
- 2004-09-16 DK DK04784389.1T patent/DK1667523T3/da active
- 2004-09-16 NZ NZ545954A patent/NZ545954A/en not_active IP Right Cessation
- 2004-09-16 CA CA2538840A patent/CA2538840C/en not_active Expired - Fee Related
- 2004-09-16 WO PCT/US2004/030512 patent/WO2005027844A2/en not_active Ceased
- 2004-09-16 PL PL04784389T patent/PL1667523T3/pl unknown
- 2004-09-16 EP EP04784389A patent/EP1667523B1/en not_active Expired - Lifetime
- 2004-09-16 JP JP2006527060A patent/JP4989224B2/ja not_active Expired - Fee Related
- 2004-09-16 BR BRPI0414442-2A patent/BRPI0414442A/pt active Search and Examination
- 2004-09-16 ES ES04784389T patent/ES2399875T3/es not_active Expired - Lifetime
- 2004-09-16 PT PT4784389T patent/PT1667523E/pt unknown
-
2006
- 2006-03-15 IL IL174325A patent/IL174325A/en not_active IP Right Cessation
-
2009
- 2009-02-09 US US12/368,151 patent/US8003113B2/en not_active Expired - Fee Related
-
2011
- 2011-07-18 US US13/185,164 patent/US8916174B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030158131A1 (en) * | 2000-10-23 | 2003-08-21 | Anna Aldovini | DNA vectors containing mutated HIV proviruses |
Non-Patent Citations (1)
| Title |
|---|
| Smith J.M. et al., Viral Immunology, 2000, Vol. no.13, no. 3, pages 343-351 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005027844A3 (en) | 2005-10-06 |
| JP4989224B2 (ja) | 2012-08-01 |
| DK1667523T3 (da) | 2013-01-21 |
| US7488485B2 (en) | 2009-02-10 |
| PT1667523E (pt) | 2013-02-04 |
| US20120207782A1 (en) | 2012-08-16 |
| IL174325A (en) | 2015-07-30 |
| US8003113B2 (en) | 2011-08-23 |
| US20050112102A1 (en) | 2005-05-26 |
| US20090233857A1 (en) | 2009-09-17 |
| AU2004273965A1 (en) | 2005-03-31 |
| CA2538840C (en) | 2014-02-18 |
| CA2538840A1 (en) | 2005-03-31 |
| US8916174B2 (en) | 2014-12-23 |
| PL1667523T3 (pl) | 2013-05-31 |
| NZ545954A (en) | 2009-04-30 |
| ES2399875T3 (es) | 2013-04-04 |
| EP1667523B1 (en) | 2012-11-21 |
| WO2005027844A2 (en) | 2005-03-31 |
| EP1667523A2 (en) | 2006-06-14 |
| IL174325A0 (en) | 2008-04-13 |
| EP1667523A4 (en) | 2007-12-19 |
| JP2007505923A (ja) | 2007-03-15 |
| BRPI0414442A (pt) | 2006-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8916174B2 (en) | HIV DNA vaccine regulated by a caev-derived promoter | |
| Voss et al. | Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine | |
| JP2011530309A (ja) | 多価ワクチン | |
| CN101969996A (zh) | 多价疫苗 | |
| US8785411B2 (en) | HIV DNA vaccine methods of use | |
| US7847085B2 (en) | Recombinant HIV-1 gp120 immunogen with three different V3 loops from viruses of different clades | |
| WO1994017825A1 (en) | Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use | |
| Warren | Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates | |
| US5876724A (en) | Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein | |
| Lecollinet et al. | Vaccination against the feline immunodeficiency virus: the road not taken | |
| EP0472706B1 (en) | Induction of protection against viral infection | |
| Singh et al. | HIV vaccine development | |
| ZA200603044B (en) | DNA vaccine compositions and methods of use | |
| MXPA06002993A (en) | Dna vaccine compositions and methods of use | |
| US20070010471A1 (en) | HIV DNA vaccine | |
| US20170107260A1 (en) | Mosaic hiv-1 sequences and uses thereof | |
| WO1993014126A1 (en) | A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus | |
| US20120321655A1 (en) | Lentivirus vaccine based on the recombinant viral vaccine against yellow fever | |
| McGettigan et al. | HIV-1 vaccines: the search continues | |
| Norley et al. | Vaccine development using the simian immunodeficiency virus model for AIDS | |
| Weaver | Phylogenetic analysis of feline immunodeficiency virus and the development of a prophylactic genetic vaccine | |
| Hostel | Efficacy and their Delivery System: A Review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |